Federal Register notice: FDA amends the animal drug regulations to include application-related actions for new animal drug applications and abbreviate...
Federal Register notice: FDA announces the issuance of Emergency Use Authorizations for certain medical devices intended for use during the Covid-19 p...
FDA accepts a Mesoblast BLA resubmission for remestemcel-L for treating children with steroid-refractory acute graft versus host disease.
An FDA safety update indicates that an agency literature review has found reports of 19 squamous cell carcinoma cases in the scar tissue (capsule) are...
Federal Register notice: FDA revokes the Emergency Use Authorizations issued for two Covid-19 diagnostics Babson Diagnostics for the Babson Diagnosti...
FDA will review a BioMarin sBLA to expand the approved achondroplasia treatment indication for Voxzogo to include children under age 5.
Covis Pharma says it is willing to work with CDER on an orderly withdrawal of Makena from the market.
Six Oncology Center of Excellence staff members describe the process used in developing a new patient-focused glossary of cancer clinical trial terms.
